biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > British Columbia Securities Commission!!

<< Previous

Bullboard Posts

Next >>

Comment by ROSIE2023on Feb 07, 2023 10:57am

138 Views

Post# 35271772

RE:RE:RE:RE:RE:RE:RE:British Columbia Securities Commission!!

Totally agreed but finding someone else's on short notice was too big a take right now
we can only hope she takes notice and she has been advised via email that the vote was not one of.confidence
She needs to wake up

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale